Empagliflozin in Hypertrophic Cardiomyopathy

NCT05182658 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Cardiomyopathy
Heart Failure

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

National Institute of Cardiology, Warsaw, Poland

Collaborators

[object Object]
[object Object]
[object Object]